• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

单细胞测序揭示三阴性乳腺癌的与线粒体自噬相关的预后模型。

Single-cell sequencing unveils mitophagy-related prognostic model for triple-negative breast cancer.

机构信息

Department of Breast Surgical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.

出版信息

Front Immunol. 2024 Nov 4;15:1489444. doi: 10.3389/fimmu.2024.1489444. eCollection 2024.

DOI:10.3389/fimmu.2024.1489444
PMID:39559367
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11570810/
Abstract

BACKGROUND

Triple-negative breast cancer (TNBC) is an aggressive subtype of breast cancer lacking hormone receptors and HER2 expression, leading to limited treatment options and poor prognosis. Mitophagy, a selective autophagy process targeting damaged mitochondria, plays a complex role in cancer progression, yet its prognostic significance in TNBC is not well understood.

METHODS

This study utilized single-cell RNA sequencing data from the TCGA and GEO databases to identify mitophagy-related genes (MRGs) associated with TNBC. A prognostic model was developed using univariate Cox analysis and LASSO regression. The model was validated across multiple independent cohorts, and correlations between MRG expression, immune infiltration, and drug sensitivity were explored.

RESULTS

Nine key MRGs were identified and used to stratify TNBC patients into high-risk and low-risk groups, with the high-risk group showing significantly worse survival outcomes. The model demonstrated strong predictive accuracy across various datasets. Additionally, the study revealed a correlation between higher MRG expression levels and increased immune cell infiltration, as well as potential responsiveness to specific chemotherapeutic agents.

CONCLUSION

The mitophagy-related prognostic model offers a novel method for predicting outcomes in TNBC patients and highlights the role of mitophagy in influencing the tumor microenvironment, with potential applications in personalized treatment strategies.

摘要

背景

三阴性乳腺癌(TNBC)是一种缺乏激素受体和 HER2 表达的侵袭性乳腺癌亚型,导致治疗选择有限,预后较差。线粒体自噬是一种靶向受损线粒体的选择性自噬过程,在癌症进展中发挥着复杂的作用,但在 TNBC 中的预后意义尚不清楚。

方法

本研究利用 TCGA 和 GEO 数据库中的单细胞 RNA 测序数据,鉴定与 TNBC 相关的线粒体自噬相关基因(MRGs)。采用单因素 Cox 分析和 LASSO 回归构建预后模型。该模型在多个独立队列中进行了验证,并探讨了 MRG 表达、免疫浸润和药物敏感性之间的相关性。

结果

鉴定出 9 个关键的 MRGs,用于将 TNBC 患者分为高危和低危组,高危组的生存结果明显较差。该模型在各种数据集上均具有较强的预测准确性。此外,研究还揭示了较高的 MRG 表达水平与增加的免疫细胞浸润之间存在相关性,以及对特定化疗药物的潜在反应性。

结论

线粒体自噬相关的预后模型为预测 TNBC 患者的预后提供了一种新方法,并强调了线粒体自噬在影响肿瘤微环境中的作用,具有潜在的个性化治疗策略应用价值。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33c4/11570810/11a3eba6d5c4/fimmu-15-1489444-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33c4/11570810/4c275fdd26f1/fimmu-15-1489444-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33c4/11570810/e8c28d2faf95/fimmu-15-1489444-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33c4/11570810/30942d876ec6/fimmu-15-1489444-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33c4/11570810/083584e680e4/fimmu-15-1489444-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33c4/11570810/b3382b8351b6/fimmu-15-1489444-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33c4/11570810/77652a134dc2/fimmu-15-1489444-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33c4/11570810/092fa94acf8a/fimmu-15-1489444-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33c4/11570810/11a3eba6d5c4/fimmu-15-1489444-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33c4/11570810/4c275fdd26f1/fimmu-15-1489444-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33c4/11570810/e8c28d2faf95/fimmu-15-1489444-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33c4/11570810/30942d876ec6/fimmu-15-1489444-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33c4/11570810/083584e680e4/fimmu-15-1489444-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33c4/11570810/b3382b8351b6/fimmu-15-1489444-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33c4/11570810/77652a134dc2/fimmu-15-1489444-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33c4/11570810/092fa94acf8a/fimmu-15-1489444-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33c4/11570810/11a3eba6d5c4/fimmu-15-1489444-g008.jpg

相似文献

1
Single-cell sequencing unveils mitophagy-related prognostic model for triple-negative breast cancer.单细胞测序揭示三阴性乳腺癌的与线粒体自噬相关的预后模型。
Front Immunol. 2024 Nov 4;15:1489444. doi: 10.3389/fimmu.2024.1489444. eCollection 2024.
2
The prognostic marker KRT81 is involved in suppressing CD8 + T cells and predicts immunotherapy response for triple-negative breast cancer.预后标志物 KRT81 可抑制 CD8+T 细胞,并预测三阴性乳腺癌的免疫治疗反应。
Cancer Biol Ther. 2024 Dec 31;25(1):2355705. doi: 10.1080/15384047.2024.2355705. Epub 2024 May 22.
3
MIR4435-2HG: A novel biomarker for triple-negative breast cancer diagnosis and prognosis, activating cancer-associated fibroblasts and driving tumor invasion through EMT associated with JNK/c-Jun and p38 MAPK signaling pathway activation.MIR4435-2HG:一种新型三阴性乳腺癌诊断和预后的生物标志物,通过 EMT 激活与 JNK/c-Jun 和 p38 MAPK 信号通路激活相关的癌相关成纤维细胞并驱动肿瘤侵袭。
Int Immunopharmacol. 2024 Dec 5;142(Pt B):113191. doi: 10.1016/j.intimp.2024.113191. Epub 2024 Sep 23.
4
Identifying the prognostic significance of mitophagy-associated genes in multiple myeloma: a novel risk model construction.鉴定多发性骨髓瘤中与线粒体自噬相关基因的预后意义:一种新的风险模型构建。
Clin Exp Med. 2024 Oct 29;24(1):249. doi: 10.1007/s10238-024-01499-6.
5
Exploring the role of mitophagy-related genes in breast cancer: subtype classification and prognosis prediction.探讨自噬相关基因在乳腺癌中的作用:亚型分类和预后预测。
Int J Med Sci. 2024 Oct 14;21(14):2664-2682. doi: 10.7150/ijms.100785. eCollection 2024.
6
Identifying prognostic biomarkers in oral squamous cell carcinoma: an integrated single-cell and bulk RNA sequencing study on mitophagy-related genes.口腔鳞状细胞癌中预后生物标志物的鉴定:基于自噬相关基因的单细胞和批量 RNA 测序综合研究。
Sci Rep. 2024 Aug 28;14(1):19992. doi: 10.1038/s41598-024-70498-0.
7
Comprehensive characterization of stemness-related lncRNAs in triple-negative breast cancer identified a novel prognostic signature related to treatment outcomes, immune landscape analysis and therapeutic guidance: a silico analysis with in vivo experiments.三阴性乳腺癌中与干性相关的长链非编码 RNA 的全面特征分析:一项与治疗结果、免疫图谱分析和治疗指导相关的新型预后标志物的计算分析及体内实验验证。
J Transl Med. 2024 May 4;22(1):423. doi: 10.1186/s12967-024-05237-0.
8
Integrated machine learning algorithms identify KIF15 as a potential prognostic biomarker and correlated with stemness in triple-negative breast cancer.集成机器学习算法鉴定 KIF15 为三阴性乳腺癌的一个潜在预后生物标志物,并与干性相关。
Sci Rep. 2024 Sep 13;14(1):21449. doi: 10.1038/s41598-024-72406-y.
9
LCP1 correlates with immune infiltration: a prognostic marker for triple-negative breast cancer.LCP1 与免疫浸润相关:三阴性乳腺癌的预后标志物。
BMC Immunol. 2024 Jul 8;25(1):42. doi: 10.1186/s12865-024-00635-x.
10
Research and experimental verification on the mechanisms of cellular senescence in triple-negative breast cancer.三阴性乳腺癌细胞衰老机制的研究与实验验证
PeerJ. 2024 Feb 29;12:e16935. doi: 10.7717/peerj.16935. eCollection 2024.

引用本文的文献

1
Targeting Mitochondrial Quality Control for the Treatment of Triple-Negative Breast Cancer: From Molecular Mechanisms to Precision Therapy.靶向线粒体质量控制用于三阴性乳腺癌治疗:从分子机制到精准治疗
Biomolecules. 2025 Jul 5;15(7):970. doi: 10.3390/biom15070970.
2
Decoding the Tumor Microenvironment of Myoepithelial Cells in Triple-Negative Breast Cancer Through Single-Cell and Transcriptomic Sequencing and Establishing a Prognostic Model Based on Key Myoepithelial Cell Genes.通过单细胞和转录组测序解码三阴性乳腺癌中肌上皮细胞的肿瘤微环境并基于关键肌上皮细胞基因建立预后模型。
Int J Genomics. 2025 May 6;2025:6454413. doi: 10.1155/ijog/6454413. eCollection 2025.
3

本文引用的文献

1
TGF-β signaling: critical nexus of fibrogenesis and cancer.TGF-β 信号转导:纤维化与癌症的关键联系。
J Transl Med. 2024 Jun 26;22(1):594. doi: 10.1186/s12967-024-05411-4.
2
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.2022 年全球癌症统计数据:全球 185 个国家和地区 36 种癌症的发病率和死亡率全球估计数。
CA Cancer J Clin. 2024 May-Jun;74(3):229-263. doi: 10.3322/caac.21834. Epub 2024 Apr 4.
3
Targeting HER2-positive breast cancer cells by a combination of dasatinib and BMS-202: Insight into the molecular pathways.
Discovery of a new mitophagy-related gene signature for predicting the outlook and immunotherapy in triple-negative breast cancer.
发现一种用于预测三阴性乳腺癌预后和免疫治疗的新的线粒体自噬相关基因特征。
Sci Rep. 2025 Feb 25;15(1):6794. doi: 10.1038/s41598-025-91613-9.
达沙替尼与BMS-202联合靶向HER2阳性乳腺癌细胞:对分子途径的深入了解
Cancer Cell Int. 2024 Mar 2;24(1):94. doi: 10.1186/s12935-023-03195-z.
4
Endothelial cells metabolically regulate breast cancer invasion toward a microvessel.内皮细胞通过代谢调节乳腺癌向微血管的侵袭。
APL Bioeng. 2023 Dec 4;7(4):046116. doi: 10.1063/5.0171109. eCollection 2023 Dec.
5
PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer.PI3K/AKT/mTOR 信号转导通路与癌症的靶向治疗。
Mol Cancer. 2023 Aug 18;22(1):138. doi: 10.1186/s12943-023-01827-6.
6
Clinical and biological heterogeneities in triple-negative breast cancer reveals a non-negligible role of HER2-low.三阴性乳腺癌的临床和生物学异质性揭示了 HER2 低表达的不可忽视作用。
Breast Cancer Res. 2023 Mar 30;25(1):34. doi: 10.1186/s13058-023-01639-y.
7
Targeting ATAD3A-PINK1-mitophagy axis overcomes chemoimmunotherapy resistance by redirecting PD-L1 to mitochondria.靶向 ATAD3A-PINK1-线粒体自噬轴通过将 PD-L1 重定向到线粒体来克服化疗免疫治疗耐药性。
Cell Res. 2023 Mar;33(3):215-228. doi: 10.1038/s41422-022-00766-z. Epub 2023 Jan 10.
8
The molecular mechanisms and therapeutic strategies of EMT in tumor progression and metastasis.肿瘤进展和转移中 EMT 的分子机制和治疗策略。
J Hematol Oncol. 2022 Sep 8;15(1):129. doi: 10.1186/s13045-022-01347-8.
9
Immune checkpoint modulators in cancer immunotherapy: recent advances and emerging concepts.癌症免疫治疗中的免疫检查点调节剂:最新进展和新兴概念。
J Hematol Oncol. 2022 Aug 17;15(1):111. doi: 10.1186/s13045-022-01325-0.
10
promotes cell proliferation and affects glycolysis in breast cancer.促进乳腺癌细胞增殖并影响糖酵解。
Exp Biol Med (Maywood). 2022 Jun;247(12):985-995. doi: 10.1177/15353702221082613. Epub 2022 Apr 11.